It's Inno Madness time! Inno Madness is our friendly, bracket-style challenge where readers vote to advance companies based ...

Perspectum today released the results of a multinational study showing that LiverMultiScan can reduce liver biopsies, lead to fewer specialist consultations, and improve the rate of diagnosis for ...

NICE today announced that it has been named a Leader in the IDC MarketScape: Worldwide Conversational Intelligence and Analytics 2024 Vendor Assessment (doc # US52047824, December 2024). A total of 16 ...

Precision Medicine Online's 2024 survey shows biomarker test expansion but low clinical trial enrollment and long wait times for advanced therapies.